Evidence map›Paper›PMID 33202795›Full record

ArticleInternational journal of molecular sciences2020

Hybrid Porous Microparticles Based on a Single Organosilica Cyclophosphazene Precursor.

Vanessa Poscher, George S Pappas, Oliver Brüggemann, Ian Teasdale, Yolanda Salinas

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 58% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. The Physical Chemistry and Chemical Physics (PCCP) Section of theInternational journal of molecular sciences · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Vanessa PoscherInstitute of Polymer Chemistry, Johannes Kepler University at Linz, Altenberger Strasse 69, 4040 Linz, Austria.
George S PappasInstitute of Polymer Chemistry, Johannes Kepler University at Linz, Altenberger Strasse 69, 4040 Linz, Austria.ORCID 0000-0002-7666-8723
Oliver BrüggemannInstitute of Polymer Chemistry, Johannes Kepler University at Linz, Altenberger Strasse 69, 4040 Linz, Austria.
Ian TeasdaleInstitute of Polymer Chemistry, Johannes Kepler University at Linz, Altenberger Strasse 69, 4040 Linz, Austria.ORCID 0000-0001-5953-9084
Yolanda SalinasInstitute of Polymer Chemistry, Johannes Kepler University at Linz, Altenberger Strasse 69, 4040 Linz, Austria.ORCID 0000-0002-1828-5839
Johannes Kepler University of Linz · AT

Funding

Austrian Science Fund LIT213760001
6 · The paper itself

Abstract

Porous organosilica microparticles consisting of silane-derived cyclophosphazene bridges were synthesized by a surfactant-mediated sol-gel process. Starting from the substitution of hexachlorocyclotriphosphazene with allylamine, two different precursors were obtained by anchoring three or six alkoxysilane units, via a thiol-ene photoaddition reaction. In both cases, spherical, microparticles (size average of ca. 1000 nm) with large pores were obtained, confirmed by both, scanning and transmission electron microscopy. Particles synthesized using the partially functionalized precursor containing free vinyl groups were further functionalized with a thiol-containing molecule. While most other reported mesoporous organosilica particles are essentially hybrids with tetraethyl orthosilicate (TEOS), a unique feature of these particles is that structural control is achieved by exclusively using organosilane precursors. This allows an increase in the proportion of the co-components and could springboard these novel phosphorus-containing organosilica microparticles for different areas of technology.

Indexed as

Organosilicon CompoundsParticle SizePorosityOrganosilicon Compoundscyclophosphazenesdegradabilityhybrid materialsporous organosilica microparticlespost-functionalization

Identifiers

PMID33202795
PMCPMC7698118
OpenAlexW3101200116

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.